Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands
NCT04885322, Not applicable, Recruiting, University of California, Davis
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands | ClinicalTrials.gov |
| NCT number | NCT04885322 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 75 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | University of California, Davis | ClinicalTrials.gov |
| Conditions | Healthy | ClinicalTrials.gov |
| Interventions | Transcranial Direct Current Stimulation | ClinicalTrials.gov |
| First posted | 2021-05-13 | ClinicalTrials.gov |
| Last updated | 2025-12-05 | ClinicalTrials.gov |
Registered outcomes 9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Behavioral Cognitive Control Measures on the Stroop Task | Through study completion, an average of 1 month | Incongruent versus Congruent difference in error rate and reaction time | ClinicalTrials.gov |
| Primary | EEG Cognitive Control Measures on the Stroop Task | Through study completion, an average of 1 month | response-locked power in the theta frequency band (4-7 Hz) | ClinicalTrials.gov |
| Primary | Behavioral Attention Lapse Measures on the Stroop Task | Through study completion, an average of 1 month | Error Rate on Incorrect Congruent trials (Full Lapses) and Slow-but-Correct Congruent trials (Partial Lapses) | ClinicalTrials.gov |
| Primary | EEG Attention Lapse Measures on the Stroop Task EEG Attention Lapse Measures on the Stroop Task | Through study completion, an average of 1 month | Pre-trial power in the alpha frequency band (8-12 Hz) | ClinicalTrials.gov |
| Primary | Behavioral Cognitive Control Measures on the Change Detection Task Behavioral Cognitive Control Measures on the Change Detection Task | Through study completion, an average of 1 month | WM storage capacity (k-max) | ClinicalTrials.gov |
| Primary | EEG Cognitive Control Measures on the Change Detection Task | Through study completion, an average of 1 month | delay period power in the theta frequency band (4-7 Hz) | ClinicalTrials.gov |
| Primary | Behavioral Attention Lapse Measures on the Change Detection Task | Through study completion, an average of 1 month | Attention factor (a); Guess factor (g) | ClinicalTrials.gov |
| Primary | EEG Attention Lapse Measures on the Change Detection Task | Through study completion, an average of 1 month | Pre-trial power in the alpha frequency band (8-12 Hz) | ClinicalTrials.gov |
| Primary | Delivered tDCS Dose to PFC | Through study completion, an average of 1 month | Estimated electric field in PFC region of interest | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 1
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)